Kurin, Inc. announces peer-reviewed publication on Kurin® efficacy from Central Texas Veterans Health Care System
Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that the Central Texas VA Health Care System in Temple, TX, published their findings comparing results of two devices: Kurin and Steripath® (Magnolia Medical Technologies, Inc.) in the online edition of the Journal of Emergency Nursing. This is the first peer-reviewed publication comparing Kurin, a passive low-volume device with flash technology to Steripath, a mechanical diversion device using a much larger volume of blood. The study concludes that both products “drastically reduced [blood culture contamination rates], irrespective of the volume of initial diversion.” During the study, use of the Kurin collection sets resulted in a blood culture contamination rate of just 0.3%.
“Congratulations to the authors from the Central Texas VA for publishing these important results,” said Bob Rogers, Inventor and CEO of Kurin. “The authors note that their results corroborate the peer-reviewed study from Hartford Hospital that showed Kurin reduced their blood culture contamination rate to below 0.5%, further strengthening the clinical foundation of Kurin.”
Kurin is the first device to allow for the passive sidelining of the initial flow of blood, providing clinicians a seamless path to compliance. Outcomes are driven by compliance and compliance is a function of how simple technology is integrated into practice, which can be particularly challenging in the busy Emergency Department. Kurin was also designed to use a remarkably low volume of blood, a significant improvement over other options, sidelining just 0.15 mls to achieve these clinical results.
“Although it is not stated in the clinical publication, after the study concluded, the facility allowed the nurses to decide which product to use and we are pleased they chose Kurin and in fact, have now been using Kurin for almost three years,” said Mr. Rogers. “Our goal is to significantly improve patient outcomes while saving hospitals significant dollars and, given the importance of the Department of Veterans Affairs to our country, there is no group we are more pleased to assist than our veterans and those providing their care.”
About Kurin, Inc.
Kurin Corporation, a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing, and sale of products that help healthcare providers reduce contaminated blood cultures. San Diego-based Kurin has received FDA 510(k) market clearance. For more information, visit the website at www.kurin.com.